Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hollie Porras, Elizabeth Johnson, Mariya Kotova, James Chenoweth & Daniel Colby. (2023) Buprenorphine Inductions via Transdermal Patches for Opioid Use Disorder in the Inpatient Setting. Journal of Pain & Palliative Care Pharmacotherapy 37:3, pages 251-256.
Read now
Read now
Nico Carswell, Giselle Angermaier, Christopher Castaneda & Fabrizzio Delgado. (2022) Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting. Hospital Practice 50:4, pages 251-258.
Read now
Read now
Consalvo Mattia, Livio Luongo, Massimo Innamorato, Luca Melis, Michele Sofia, Lucia Zappi & Filomena Puntillo. (2021) An Italian Expert Consensus on the Use of Opioids for the Management of Chronic Non-Oncological Pain in Clinical Practice: Focus on Buprenorphine.. Journal of Pain Research 14, pages 3193-3206.
Read now
Read now
Joseph V Pergolizzi$suffix/text()$suffix/text(), Peter Magnusson, Jo Ann LeQuang, Frank Breve, Kailyn Mitchell, Maninder Chopra & Giustino Varrassi. (2021) Transdermal Buprenorphine for Acute Pain in the Clinical Setting: A Narrative Review. Journal of Pain Research 14, pages 871-879.
Read now
Read now
Matthew Degnan & Shaker A. Mousa. (2020) A narrative review of buprenorphine in adult cancer pain. Expert Review of Clinical Pharmacology 13:10, pages 1159-1167.
Read now
Read now
Nelson E. Sessler, Ekaterina Walker, Harsha Chickballapur, James Kacholakalayil & Paul M. Coplan. (2017) Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data. Postgraduate Medicine 129:1, pages 62-68.
Read now
Read now
Articles from other publishers (16)
Lindsey Wang, Nora D. Volkow, Nathan A. Berger, Pamela B. Davis, David C. Kaelber & Rong Xu. (2023) Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder. Journal of Clinical Psychology 79:12, pages 2869-2883.
Crossref
Crossref
Claire Brandt & Timothy J. Atkinson. (2022) A review of the safety of buprenorphine in special populations. The American Journal of the Medical Sciences 364:6, pages 675-684.
Crossref
Crossref
Todd A. Miano, Lei Wang, Charles E. Leonard, Colleen M. Brensinger, Emily K. Acton, Ghadeer K. Dawwas, Warren B. Bilker, Samantha E. Soprano, Thanh Phuong Pham Nguyen, George Woody, Elmer Yu, Mark Neuman, Lang Li & Sean Hennessy. (2022) Identifying Clinically Relevant Drug–Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection. Clinical Pharmacology & Therapeutics 112:5, pages 1120-1129.
Crossref
Crossref
Farshid Etaee, Morgan Tobin, Suchith Vuppala, Alireza Komaki, Brian P. Delisle, Luigi Di Biase, John N Catanzaro, Andrea Natale & Claude S. Elayi. (2021) Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article. Journal of Interventional Cardiac Electrophysiology 63:2, pages 471-500.
Crossref
Crossref
Daniel G. Tobin, Mark B. Lockwood, Paul L. Kimmel, Laura M. Dember, Nwamaka D. Eneanya, Manisha Jhamb, Thomas D. Nolin, William C. Becker & Michael J. Fischer. (2021) Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nature Reviews Nephrology 18:2, pages 113-128.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
511
774
.
Sandra C Bishop-Freeman, Laura W Friederich, Marc S Feaster & Jason S Hudson. (2021) Buprenorphine-Related Deaths in North Carolina from 2010 to 2018. Journal of Analytical Toxicology 45:8, pages 780-791.
Crossref
Crossref
Saeed Ahmed, Siddhi Bhivandkar, Brady B. Lonergan & Joji Suzuki. (2020) Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American Journal on Addictions 30:4, pages 305-315.
Crossref
Crossref
Ersin Yildirim, Murat Selcuk, Faysal Saylik, Ferit Onur Mutluer & Ozgur Deniz. (2020) Efeitos da Heroína nos Parâmetros Eletrocardiográficos. Arquivos Brasileiros de Cardiologia 115:6, pages 1135-1141.
Crossref
Crossref
Phu N. Tran, Jiansong Sheng, Aaron L. Randolph, Claudia Alvarez Baron, Nicolas Thiebaud, Ming Ren, Min Wu, Lars Johannesen, Donna A. Volpe, Dakshesh Patel, Ksenia Blinova, David G. Strauss & Wendy W. Wu. (2020) Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block. PLOS ONE 15:11, pages e0241362.
Crossref
Crossref
Jillian L. Kyzer & Cody J. Wenthur. (2020) Classics in Chemical Neuroscience: Buprenorphine. ACS Chemical Neuroscience 11:10, pages 1385-1399.
Crossref
Crossref
Richard J. Bodnar. (2020) Endogenous opiates and behavior: 2017. Peptides 124, pages 170223.
Crossref
Crossref
Mellar P. Davis, Gavril Pasternak & Bertrand Behm. (2018) Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 78:12, pages 1211-1228.
Crossref
Crossref
Richard C. Crist, Toni-Kim Clarke & Wade H. Berrettini. (2018) Pharmacogenetics of Opioid Use Disorder Treatment. CNS Drugs 32:4, pages 305-320.
Crossref
Crossref
Paul D Gavin, Lee S Simon, Thomas Schlagheck, Alisha J Smith & Janakan Krishnarajah. (2017) A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system. Pain Management 7:6, pages 499-512.
Crossref
Crossref
Geoffrey K. Isbister, Amanda L. Brown, Anthony Gill, Alexander J. Scott, Leonie Calver & Adrian J. Dunlop. (2017) QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings. British Journal of Clinical Pharmacology 83:10, pages 2274-2282.
Crossref
Crossref